CN Stock MarketDetailed Quotes

600161 Beijing Tiantan Biological Products Corporation

Watchlist
  • 19.80
  • -0.09-0.45%
Market Closed Jan 6 15:00 CST
39.15BMarket Cap30.75P/E (TTM)

Beijing Tiantan Biological Products Corporation Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
1.28%4.07B
5.59%2.84B
-5.42%1.22B
21.57%5.18B
38.09%4.02B
42.34%2.69B
83.30%1.29B
3.63%4.26B
3.36%2.91B
4.37%1.89B
Operating revenue
1.28%4.07B
5.59%2.84B
-5.42%1.22B
21.57%5.18B
38.09%4.02B
42.34%2.69B
83.30%1.29B
3.63%4.26B
3.36%2.91B
4.37%1.89B
Other operating revenue
----
23.82%10.55M
----
9.03%18.38M
----
6.95%8.52M
----
15.10%16.86M
----
32.89%7.97M
Total operating cost
-8.42%2.4B
-5.80%1.68B
-18.18%722.8M
17.99%3.43B
31.43%2.62B
37.71%1.78B
70.55%883.4M
1.17%2.91B
4.79%1.99B
4.20%1.3B
Operating cost
-10.22%1.82B
-9.05%1.26B
-23.07%536.72M
17.54%2.55B
35.70%2.03B
43.02%1.38B
91.57%697.68M
0.57%2.17B
3.43%1.49B
2.70%968.32M
Operating tax surcharges
6.52%41.58M
10.27%29.19M
10.16%12.3M
8.29%48.64M
36.82%39.04M
40.61%26.47M
29.51%11.16M
-4.57%44.92M
-9.60%28.53M
-10.54%18.83M
Operating expense
-39.71%119.81M
-27.59%110.75M
-19.97%55.53M
3.22%270.52M
0.41%198.71M
19.82%152.95M
13.52%69.38M
-3.22%262.08M
2.91%197.89M
5.21%127.66M
Administration expense
5.76%348.45M
9.43%235.88M
6.24%108.23M
28.36%469.46M
40.11%329.48M
39.69%215.55M
31.09%101.88M
11.30%365.75M
10.97%235.16M
13.90%154.31M
Financial expense
10.87%-30.25M
-9.36%-23.69M
-130.96%-14.43M
14.60%-49.53M
22.91%-33.94M
31.96%-21.66M
61.63%-6.25M
9.60%-57.99M
10.50%-44.03M
-45.65%-31.84M
-Interest expense (Financial expense)
-5.79%3.81M
-4.00%2.55M
-78.57%1.2M
51.58%3.65M
143.18%4.05M
136.25%2.66M
--5.59M
-21.96%2.41M
27.50%1.66M
-13.74%1.13M
-Interest Income (Financial expense)
8.14%-36.31M
-9.35%-27.74M
-4.27%-12.52M
10.53%-55.53M
19.66%-39.53M
24.82%-25.36M
29.90%-12.01M
9.95%-62.06M
7.41%-49.2M
-35.13%-33.74M
Research and development
69.15%98.7M
166.36%68.97M
156.34%24.45M
14.70%139.95M
-28.07%58.35M
-55.55%25.89M
-57.85%9.54M
-8.40%122.01M
14.83%81.12M
30.88%58.25M
Credit Impairment Loss
233.80%1.81M
-248.22%-1.61M
-89.95%87.69K
-596.74%-2.01M
-8,100.13%-1.35M
24.31%-462.12K
427.39%872.2K
76.69%-288.51K
97.68%-16.46K
-30.18%-610.58K
Asset Impairment Loss
-319.76%-1.57M
203.94%179.85K
-65.36%-243.2K
3.85%-2.17M
-334.69%-374.76K
-165.42%-173.03K
27.14%-147.07K
85.12%-2.25M
985.80%159.68K
323.57%264.47K
Other net revenue
32.50%51.15M
11.07%30.83M
-8.89%17.11M
-30.01%54.32M
-30.48%38.6M
-3.08%27.76M
-5.21%18.78M
1,198.66%77.6M
320.01%55.53M
199.79%28.64M
Invest income
15.65%31.2M
37.67%23.05M
21.29%10.23M
32.31%37.21M
33.85%26.98M
45.20%16.74M
50.00%8.44M
134.39%28.13M
--20.16M
--11.53M
Asset deal income
1,898.47%37.5K
1,898.47%37.5K
----
-100.33%-51.78K
-100.01%-2.09K
---2.09K
----
2,952.74%15.63M
160.80%15.44M
----
Other revenue
47.39%19.68M
-21.28%9.17M
-26.88%7.03M
-41.39%21.33M
-32.52%13.35M
-33.24%11.65M
-34.39%9.61M
269.59%36.4M
146.51%19.79M
313.78%17.45M
Operating profit
19.72%1.73B
27.49%1.19B
20.80%516.26M
26.04%1.8B
47.78%1.44B
49.85%934.62M
106.78%427.36M
15.04%1.43B
4.95%975.92M
7.98%623.69M
Add:Non operating Income
-77.25%408.97K
-76.80%240.78K
-85.18%102.04K
80.68%5M
-38.16%1.8M
215.96%1.04M
191.00%688.54K
336.68%2.77M
732.02%2.91M
184.88%328.43K
Less:Non operating expense
-14.21%2.57M
140.19%1.44M
54.41%143.62K
32.38%11.4M
-36.70%3M
-20.89%598.23K
-79.36%93.02K
90.39%8.61M
70.45%4.73M
23.38%756.23K
Total profit
19.66%1.72B
27.30%1.19B
20.63%516.22M
26.10%1.8B
47.94%1.44B
50.03%935.06M
107.28%427.95M
14.93%1.43B
5.03%974.09M
8.00%623.27M
Less:Income tax cost
27.25%297.04M
27.39%204.91M
21.93%84.1M
30.48%289.14M
57.52%233.44M
71.11%160.86M
123.19%68.97M
28.68%221.6M
8.02%148.19M
6.75%94.01M
Net profit
18.20%1.43B
27.29%985.46M
20.38%432.13M
25.30%1.51B
46.22%1.21B
46.28%774.2M
104.49%358.98M
12.71%1.2B
4.51%825.9M
8.23%529.26M
Net profit from continuing operation
18.20%1.43B
27.29%985.46M
20.38%432.13M
25.30%1.51B
46.22%1.21B
46.28%774.2M
104.49%358.98M
12.71%1.2B
4.51%825.9M
8.23%529.26M
Less:Minority Profit
17.32%375.67M
25.06%259.37M
18.93%115.45M
23.42%399.57M
42.29%320.22M
43.73%207.4M
92.69%97.07M
4.84%323.76M
-3.07%225.04M
-5.15%144.3M
Net profit of parent company owners
18.52%1.05B
28.10%726.09M
20.91%316.67M
25.99%1.11B
47.69%887.4M
47.24%566.8M
109.23%261.91M
15.91%880.92M
7.67%600.86M
14.27%384.95M
Earning per share
Basic earning per share
17.78%0.53
27.59%0.37
18.75%0.19
26.42%0.67
25.00%0.45
26.09%0.29
100.00%0.16
12.77%0.53
2.86%0.36
4.55%0.23
Diluted earning per share
17.78%0.53
27.59%0.37
18.75%0.19
26.42%0.67
25.00%0.45
26.09%0.29
100.00%0.16
12.77%0.53
2.86%0.36
4.55%0.23
Other composite income
19.1M
19.1M
Other composite income of parent company owners
--14.13M
--14.13M
----
----
----
----
----
----
----
----
Other composite income of minority owners
--4.96M
--4.96M
----
----
----
----
----
----
----
----
Total composite income
19.78%1.45B
29.75%1B
20.38%432.13M
25.30%1.51B
46.22%1.21B
46.28%774.2M
104.49%358.98M
12.71%1.2B
4.51%825.9M
8.23%529.26M
Total composite income of parent company owners
20.11%1.07B
30.60%740.22M
20.91%316.67M
25.99%1.11B
47.69%887.4M
47.24%566.8M
109.23%261.91M
15.91%880.92M
7.67%600.86M
14.27%384.95M
Total composite income of minority owners
18.87%380.64M
27.45%264.33M
18.93%115.45M
23.42%399.57M
42.29%320.22M
43.73%207.4M
92.69%97.07M
4.84%323.76M
-3.07%225.04M
-5.15%144.3M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 1.28%4.07B5.59%2.84B-5.42%1.22B21.57%5.18B38.09%4.02B42.34%2.69B83.30%1.29B3.63%4.26B3.36%2.91B4.37%1.89B
Operating revenue 1.28%4.07B5.59%2.84B-5.42%1.22B21.57%5.18B38.09%4.02B42.34%2.69B83.30%1.29B3.63%4.26B3.36%2.91B4.37%1.89B
Other operating revenue ----23.82%10.55M----9.03%18.38M----6.95%8.52M----15.10%16.86M----32.89%7.97M
Total operating cost -8.42%2.4B-5.80%1.68B-18.18%722.8M17.99%3.43B31.43%2.62B37.71%1.78B70.55%883.4M1.17%2.91B4.79%1.99B4.20%1.3B
Operating cost -10.22%1.82B-9.05%1.26B-23.07%536.72M17.54%2.55B35.70%2.03B43.02%1.38B91.57%697.68M0.57%2.17B3.43%1.49B2.70%968.32M
Operating tax surcharges 6.52%41.58M10.27%29.19M10.16%12.3M8.29%48.64M36.82%39.04M40.61%26.47M29.51%11.16M-4.57%44.92M-9.60%28.53M-10.54%18.83M
Operating expense -39.71%119.81M-27.59%110.75M-19.97%55.53M3.22%270.52M0.41%198.71M19.82%152.95M13.52%69.38M-3.22%262.08M2.91%197.89M5.21%127.66M
Administration expense 5.76%348.45M9.43%235.88M6.24%108.23M28.36%469.46M40.11%329.48M39.69%215.55M31.09%101.88M11.30%365.75M10.97%235.16M13.90%154.31M
Financial expense 10.87%-30.25M-9.36%-23.69M-130.96%-14.43M14.60%-49.53M22.91%-33.94M31.96%-21.66M61.63%-6.25M9.60%-57.99M10.50%-44.03M-45.65%-31.84M
-Interest expense (Financial expense) -5.79%3.81M-4.00%2.55M-78.57%1.2M51.58%3.65M143.18%4.05M136.25%2.66M--5.59M-21.96%2.41M27.50%1.66M-13.74%1.13M
-Interest Income (Financial expense) 8.14%-36.31M-9.35%-27.74M-4.27%-12.52M10.53%-55.53M19.66%-39.53M24.82%-25.36M29.90%-12.01M9.95%-62.06M7.41%-49.2M-35.13%-33.74M
Research and development 69.15%98.7M166.36%68.97M156.34%24.45M14.70%139.95M-28.07%58.35M-55.55%25.89M-57.85%9.54M-8.40%122.01M14.83%81.12M30.88%58.25M
Credit Impairment Loss 233.80%1.81M-248.22%-1.61M-89.95%87.69K-596.74%-2.01M-8,100.13%-1.35M24.31%-462.12K427.39%872.2K76.69%-288.51K97.68%-16.46K-30.18%-610.58K
Asset Impairment Loss -319.76%-1.57M203.94%179.85K-65.36%-243.2K3.85%-2.17M-334.69%-374.76K-165.42%-173.03K27.14%-147.07K85.12%-2.25M985.80%159.68K323.57%264.47K
Other net revenue 32.50%51.15M11.07%30.83M-8.89%17.11M-30.01%54.32M-30.48%38.6M-3.08%27.76M-5.21%18.78M1,198.66%77.6M320.01%55.53M199.79%28.64M
Invest income 15.65%31.2M37.67%23.05M21.29%10.23M32.31%37.21M33.85%26.98M45.20%16.74M50.00%8.44M134.39%28.13M--20.16M--11.53M
Asset deal income 1,898.47%37.5K1,898.47%37.5K-----100.33%-51.78K-100.01%-2.09K---2.09K----2,952.74%15.63M160.80%15.44M----
Other revenue 47.39%19.68M-21.28%9.17M-26.88%7.03M-41.39%21.33M-32.52%13.35M-33.24%11.65M-34.39%9.61M269.59%36.4M146.51%19.79M313.78%17.45M
Operating profit 19.72%1.73B27.49%1.19B20.80%516.26M26.04%1.8B47.78%1.44B49.85%934.62M106.78%427.36M15.04%1.43B4.95%975.92M7.98%623.69M
Add:Non operating Income -77.25%408.97K-76.80%240.78K-85.18%102.04K80.68%5M-38.16%1.8M215.96%1.04M191.00%688.54K336.68%2.77M732.02%2.91M184.88%328.43K
Less:Non operating expense -14.21%2.57M140.19%1.44M54.41%143.62K32.38%11.4M-36.70%3M-20.89%598.23K-79.36%93.02K90.39%8.61M70.45%4.73M23.38%756.23K
Total profit 19.66%1.72B27.30%1.19B20.63%516.22M26.10%1.8B47.94%1.44B50.03%935.06M107.28%427.95M14.93%1.43B5.03%974.09M8.00%623.27M
Less:Income tax cost 27.25%297.04M27.39%204.91M21.93%84.1M30.48%289.14M57.52%233.44M71.11%160.86M123.19%68.97M28.68%221.6M8.02%148.19M6.75%94.01M
Net profit 18.20%1.43B27.29%985.46M20.38%432.13M25.30%1.51B46.22%1.21B46.28%774.2M104.49%358.98M12.71%1.2B4.51%825.9M8.23%529.26M
Net profit from continuing operation 18.20%1.43B27.29%985.46M20.38%432.13M25.30%1.51B46.22%1.21B46.28%774.2M104.49%358.98M12.71%1.2B4.51%825.9M8.23%529.26M
Less:Minority Profit 17.32%375.67M25.06%259.37M18.93%115.45M23.42%399.57M42.29%320.22M43.73%207.4M92.69%97.07M4.84%323.76M-3.07%225.04M-5.15%144.3M
Net profit of parent company owners 18.52%1.05B28.10%726.09M20.91%316.67M25.99%1.11B47.69%887.4M47.24%566.8M109.23%261.91M15.91%880.92M7.67%600.86M14.27%384.95M
Earning per share
Basic earning per share 17.78%0.5327.59%0.3718.75%0.1926.42%0.6725.00%0.4526.09%0.29100.00%0.1612.77%0.532.86%0.364.55%0.23
Diluted earning per share 17.78%0.5327.59%0.3718.75%0.1926.42%0.6725.00%0.4526.09%0.29100.00%0.1612.77%0.532.86%0.364.55%0.23
Other composite income 19.1M19.1M
Other composite income of parent company owners --14.13M--14.13M--------------------------------
Other composite income of minority owners --4.96M--4.96M--------------------------------
Total composite income 19.78%1.45B29.75%1B20.38%432.13M25.30%1.51B46.22%1.21B46.28%774.2M104.49%358.98M12.71%1.2B4.51%825.9M8.23%529.26M
Total composite income of parent company owners 20.11%1.07B30.60%740.22M20.91%316.67M25.99%1.11B47.69%887.4M47.24%566.8M109.23%261.91M15.91%880.92M7.67%600.86M14.27%384.95M
Total composite income of minority owners 18.87%380.64M27.45%264.33M18.93%115.45M23.42%399.57M42.29%320.22M43.73%207.4M92.69%97.07M4.84%323.76M-3.07%225.04M-5.15%144.3M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Bird Flu
Bird Flu
Intraday+2.74%
Virus Prevention
Virus Prevention
Intraday+1.87%
Blood Products Concept
Blood Products Concept
Intraday+0.44%